170 related articles for article (PubMed ID: 1328668)
1. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion.
Moscona A; Peluso RW
J Virol; 1992 Nov; 66(11):6280-7. PubMed ID: 1328668
[TBL] [Abstract][Full Text] [Related]
2. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
3. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.
Ah-Tye C; Schwartz S; Huberman K; Carlin E; Moscona A
Microb Pathog; 1999 Nov; 27(5):329-36. PubMed ID: 10545258
[TBL] [Abstract][Full Text] [Related]
4. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity.
Moscona A; Peluso RW
J Virol; 1993 Nov; 67(11):6463-8. PubMed ID: 8411349
[TBL] [Abstract][Full Text] [Related]
5. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion.
Moscona A; Peluso RW
J Virol; 1991 Jun; 65(6):2773-7. PubMed ID: 1851852
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
[TBL] [Abstract][Full Text] [Related]
7. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
Porotto M; Greengard O; Poltoratskaia N; Horga MA; Moscona A
J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020
[TBL] [Abstract][Full Text] [Related]
8. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle.
Huberman K; Peluso RW; Moscona A
Virology; 1995 Dec; 214(1):294-300. PubMed ID: 8525632
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor.
Moscona A; Peluso RW
Microb Pathog; 1996 Mar; 20(3):179-84. PubMed ID: 8965678
[TBL] [Abstract][Full Text] [Related]
10. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Murrell M; Porotto M; Weber T; Greengard O; Moscona A
J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
[TBL] [Abstract][Full Text] [Related]
11. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
Greengard O; Poltoratskaia N; Leikina E; Zimmerberg J; Moscona A
J Virol; 2000 Dec; 74(23):11108-14. PubMed ID: 11070006
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of interference mediated by human parainfluenza virus type 3 infection.
Horga MA; Gusella GL; Greengard O; Poltoratskaia N; Porotto M; Moscona A
J Virol; 2000 Dec; 74(24):11792-9. PubMed ID: 11090179
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.
Prince GA; Ottolini MG; Moscona A
J Virol; 2001 Dec; 75(24):12446-51. PubMed ID: 11711635
[TBL] [Abstract][Full Text] [Related]
14. Persistent infection with human parainfluenza virus 3 in CV-1 cells: analysis of the role of defective interfering particles.
Moscona A; Peluso RW
Virology; 1993 May; 194(1):399-402. PubMed ID: 8386885
[TBL] [Abstract][Full Text] [Related]
15. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins.
Heminway BR; Yu Y; Galinski MS
Virus Res; 1994 Jan; 31(1):1-16. PubMed ID: 8165862
[TBL] [Abstract][Full Text] [Related]
16. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells
Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535
[TBL] [Abstract][Full Text] [Related]
17. Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase.
Iorio RM; Glickman RL
J Virol; 1992 Nov; 66(11):6626-33. PubMed ID: 1404607
[TBL] [Abstract][Full Text] [Related]
18. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease.
Moscona A
J Clin Invest; 2005 Jul; 115(7):1688-98. PubMed ID: 16007245
[TBL] [Abstract][Full Text] [Related]
19. Immediate persistent infection by human parainfluenza virus 3: unique fusion properties of the persistently infected cells.
Wechsler SL; Lambert DM; Galinski MS; Mink MA; Rochovansky O; Pons MW
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1737-48. PubMed ID: 2438380
[TBL] [Abstract][Full Text] [Related]
20. Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.
Palermo LM; Porotto M; Yokoyama CC; Palmer SG; Mungall BA; Greengard O; Niewiesk S; Moscona A
J Virol; 2009 Jul; 83(13):6900-8. PubMed ID: 19386708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
